Neuphoria announces initiation of strategic review
Source: SeekingAlpha
2025-11-11 07:09:06 ET
More on Neuphoria Therapeutics Inc.
- Seeking Alpha’s Quant Rating on Neuphoria Therapeutics Inc.
- Historical earnings data for Neuphoria Therapeutics Inc.
- Financial information for Neuphoria Therapeutics Inc.
Read the full article on Seeking Alpha
For further details see:
Neuphoria announces initiation of strategic review
Neuphoria Therapeutics Inc.
NASDAQ: NEUP
NEUP Trading
-1.19% G/L:
$4.55 Last:
54,635 Volume:
$4.48 Open:
NEUP Latest News
December 08, 2025 08:00:00 am
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees
December 04, 2025 08:00:00 am
Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium
NEUP Stock Data
$21,778,182
4,898,747
16.28%
4
N/A
Biotechnology & Life Sciences
Healthcare
AU
Burlington
